Circalux

Circalux Overview

Founded 2016
Founded
Status Private
Latest Deal Type Crowdfunding (Cancelled)
Investors 3

Circalux General Information

Description

Developer of a portable circadian-friendly light designed to minimize sleep disruption and improve patient outcomes. The company's smart and portable LED lantern is basically designed for hospital care to diminish light pollution in patient rooms and can be used anywhere where non-disruptive illumination is needed, enabling caregivers to perform their overnight care tasks without disrupting the sleeping pattern of their patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Electronics (B2C)
Primary Office
  • Philadelphia, PA
  • United States

Circalux Timeline

2017201820192020
Date FoundedFinancing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Circalux Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Product Crowdfunding 28-Jun-2017 Cancelled Generating Revenue
3. Accelerator/Incubator 07-Jun-2017 0000 Completed Generating Revenue
2. Grant 18-Apr-2017 $10K Completed Generating Revenue
1. Grant 14-Dec-2016 Completed Generating Revenue

Circalux Executive Team (4)

Name Title Board Seat Contact Info
Lorenzo Albala Co-Founder & Chief Executive Officer
Dave Hanrahan Chief Financial Officer & Chief Business Development Officer
Tim Bober Co-Founder & Chief Communication Expert
Graham Hale Co-Founder

Circalux Investors (3)

To view Circalux‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Nextfab Accelerator/Incubator 000 0000 000000 0
Thomas Jefferson University University 000 0000 000000 0
Ben Franklin Technology Partner of Southeastern Pennsylvania Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial